Jayasundara Hishali D, Herath Lasitha Y, Kularatne Keertie S
Medicine, National Hospital Kandy, Kandy, LKA.
Cureus. 2021 Sep 6;13(9):e17760. doi: 10.7759/cureus.17760. eCollection 2021 Sep.
Acquired hemophilia A (AHA) is a different bleeding disorder to that of classic hemophilia A. It is an autoimmune-mediated bleeding disorder due to the presence of autoantibodies (inhibitors) directed against plasma coagulation factor VIII. This can result in fatal hemorrhage; thus, eradication of the antibody is the mainstay of treatment. Nontraumatic retrobulbar hemorrhage is a very rare presentation of hemophilia. We report an elderly male presenting with retrobulbar hemorrhage secondary to AHA who was successfully treated with immunosuppression.
获得性血友病A(AHA)是一种与经典血友病A不同的出血性疾病。它是一种自身免疫介导的出血性疾病,由于存在针对血浆凝血因子VIII的自身抗体(抑制剂)。这可能导致致命性出血;因此,消除抗体是治疗的主要方法。非创伤性球后出血是血友病非常罕见的表现。我们报告一例继发于AHA的球后出血老年男性患者,经免疫抑制治疗成功治愈。